To Assess the Outcomes Associated With the Use of Tranexamic Acid in the Open Fixation of Pelvic and Acetabular Fractures

There is a growing knowledge base for the use of antifibrinolytic therapy in trauma and orthopaedic surgery. The mechanism of action of tranexamic acid (TXA) is through the inhibition of fibrinolysis. The role of TXA in hip fractures has been researched extensively. However, the research has been limited to the cases of pelvic and acetabular fractures. This systematic review aimed to examine the effect of TXA on patients undergoing open pelvic and acetabular fracture surgery. The primary goal of the study was to examine the estimated blood loss (EBL) and blood transfusion rates in patients who received TXA versus those who did not receive TXA. The secondary goal was to examine the rates of deep venous thrombosis (DVT). A literature search was carried out using PubMed, Medline and the Cochrane database. The selection criteria for the systematic review were studies investigating intravenous TXA in the form of randomised controlled trials (RCTs), as well as cohort studies. Five studies were included in the systematic review with 625 total patients. The EBL between the two groups was noted to be 661 mL in the control group and 850 mL in the TXA (p=0.49). There was a marginally lower number of units transfused in the control group vs the TXA group (1.9 vs 2.2) (p=0.27). The rates of transfusion in the TXA group were 29% TXA whilst, in the control group, it was 31% (p=0.13). The overall incidence of DVT was 2.8% in the TXA group and 1.7% in the control group (p=0.097).

[1]  T. Mathes,et al.  Association of Tranexamic Acid Administration With Mortality and Thromboembolic Events in Patients With Traumatic Injury , 2022, JAMA network open.

[2]  Henry T. Shu,et al.  Tranexamic acid use in pelvic and/or acetabular fracture surgery: A systematic review and meta-analysis. , 2021, Journal of orthopaedics.

[3]  M. Gardner,et al.  Tranexamic acid does not affect intraoperative blood loss or in-hospital outcomes after acetabular fracture surgery , 2021, European Journal of Orthopaedic Surgery & Traumatology.

[4]  T. Onay,et al.  The efficiency and safety of intravenous tranexamic acid administration in open reduction and internal fixation of pelvic and acetabular fractures , 2021, European Journal of Trauma and Emergency Surgery.

[5]  T. Vail,et al.  The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty: A Multicenter Randomized Clinical Trial. , 2020, The Journal of bone and joint surgery. American volume.

[6]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[7]  Stephen M. Quinnan,et al.  Tranexamic acid with a pre-operative suspension of anticoagulation decreases operative time and blood transfusion in the treatment of pelvic and acetabulum fractures , 2020, International Orthopaedics.

[8]  W. Alhazzani,et al.  Use of the GRADE approach in systematic reviews and guidelines. , 2019, British journal of anaesthesia.

[9]  Hilary Thomson,et al.  Summarizing study characteristics and preparing for synthesis , 2019, Cochrane Handbook for Systematic Reviews of Interventions.

[10]  Michael J. Hankins,et al.  Tranexamic Acid Use in Open Reduction and Internal Fixation of Fractures of the Pelvis, Acetabulum, and Proximal Femur: A Randomized Controlled Trial. , 2019, Journal of orthopaedic trauma.

[11]  K. Titlestad,et al.  Introduction of national guidelines for restrictive blood transfusion threshold for hip fracture patients––a consecutive cohort study based on complete follow-up in national databases , 2018, Journal of Orthopaedic Surgery and Research.

[12]  D. Jevsevar,et al.  The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis. , 2018, The Journal of arthroplasty.

[13]  R. Seymour,et al.  Effect of Tranexamic Acid on Transfusion: A Randomized Clinical Trial in Acetabular Fracture Surgery , 2017, Journal of orthopaedic trauma.

[14]  D. Lorich,et al.  Tranexamic Acid in Orthopaedic Trauma Surgery: A Meta-Analysis , 2017, Journal of orthopaedic trauma.

[15]  P. Myint,et al.  A systematic review of tranexamic acid in hip fracture surgery. , 2016, British journal of clinical pharmacology.

[16]  Loet Leydesdorff,et al.  Cited references and Medical Subject Headings (MeSH) as two different knowledge representations: clustering and mappings at the paper level , 2016, Scientometrics.

[17]  N. Foss,et al.  Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial. , 2016, The bone & joint journal.

[18]  R. Sierra,et al.  Tranexamic Acid in Hip and Knee Arthroplasty , 2015, Journal of the American Academy of Orthopaedic Surgeons.

[19]  Phil Edwards,et al.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis , 2012, BMJ : British Medical Journal.

[20]  K. Michaëlsson,et al.  Cardiovascular diseases and risk of hip fracture. , 2009, JAMA.

[21]  J. Keating,et al.  Acetabular fractures: a 16-year prospective epidemiological study. , 2005, The Journal of bone and joint surgery. British volume.

[22]  K. Slim,et al.  Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument , 2003, ANZ journal of surgery.

[23]  Thomas M Scalea,et al.  Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. , 2003, The Journal of trauma.

[24]  A. Peitzman,et al.  Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism , 2019, The journal of trauma and acute care surgery.

[25]  Frandsen,et al.  Syddansk Universitet The impact of patient , intervention , comparison , outcome ( PICO ) as a search strategy tool on literature search quality a systematic review , 2018 .

[26]  M. M. Peng Zhang,et al.  Combined versus single application of tranexamic acid in total knee and hip arthroplasty: A meta-analysis of randomized controlled trials. , 2017, International journal of surgery.